Manulife Vitality
Frequently Asked Questions
Rx Report™ is a pharmacist-assisted genetic drug compatibility test offered by Personalized Prescribing Inc. to identify the most effective psychotropic medications with the least number of side effects
Opti-Med is a pharmacogenetics report that can be viewed on a computer or uploaded on a phone. It provides high level evidence on metabolism (clearance) of 80% of the drugs commercially available. It does not provide information on efficacy of drugs.
Click HERE to see our RxReport Drug List.
Click HERE to see our Opti-Med Drug List.
For both tests, it takes 5-7 business days to complete the analysis after we receive your swab sample at our laboratory.
The website price for RxReport is $499 plus HST, however, for Manulife Vitality members, the price is $439 plus HST.
The Website price of Opti-Med is $199 plus HST, however, for Manulife Vitality members, the price is $179 plus HST.
Sample collection instructions will be sent to you with the DNA sample kit. You need to follow the instructions to collect the sample and return the prepaid envelope to our lab by Canada Post.
Patients should not eat or drink for 30 minutes before taking the sample. Also, it is better they brush their teeth 30 minutes before they collect the swab.
No, the shipment charge is included in the price.
For RxReport, the pharmacist sends the summary report via email. A link with the patient’s unique login ID and password will also be sent to them to view their genetic report.
For Opti-Med, patients will receive an email notification with a patient’s unique login ID and password and instructions to download the app on their phone, or view their genetic metabolism report.
The genetic test analysis is 99.99% accurate. However, the interpretation of the test results is done by our pharmacists. They use the latest scientific publications and evidence available in various scientific platforms to interpret the test results and provide recommendations.
Rx Report™ test is supported by compelling scientific evidence available on multiple health sciences platforms such as PharmGKB, Clinical Pharmacogenetics Implementation Consortium (CPIC), Food and Drug Administration (FDA), etcetera. The tests analyze up to 54 genes and 104 genetic variations.
All information that is provided is kept private and confidential, and information is only used on an aggregate level (for statistical purposes) to improve our services, showcase medication response patterns via research publications, and inform the care of future patients.
In addition, because of the Genetic Anti-Discrimination Act passed in April 2017, no person or entity may discriminate against any individual based on their genetic information.
